From the Journals

Meta-analysis shows correlation between diabetes and erectile dysfunction


 

FROM DIABETIC MEDICINE

– More than half of men with type 1 or type 2 diabetes develop erectile dysfunction, making them more than three times as likely to develop ED, compared with healthy men, according to a systematic review of diabetes studies.

Data on the exact prevalence of erectile dysfunction in this population has been lacking until now. More precise figures are available from a meta-analysis of 145 studies taken from international diabetes databases.

©Tashatuvango/Thinkstockphotos.com
The prevalence of erectile dysfunction in diabetes overall was 52.5% (95% confidence interval, 48.8-56.2) after adjusting for publication bias, and 37.5%, 66.3%, and 57.7% in type 1, type 2, and both types of diabetes, respectively (P for interaction less than .0001).

In terms of risk, men with diabetes were 3.62 (95% CI, 2.53-5.16; P less than .0001) times more likely to develop ED, compared with healthy controls, according to investigators (Diabet Med. 2017 Jul 18. doi: 10.1111/dme.13403).

“Regarding sexual activity and the psychological impact of erectile dysfunction in men with diabetes mellitus, significant and positive associations have been found between depressive symptoms and erectile dysfunction,” said Youssef Kouidrat, MD, PhD, of the department of psychosis studies, Institute of Psychiatry, King’s College London, and his fellow researchers. “Therefore, early detection of erectile dysfunction is essential to improve the psychological health and men’s quality of life.”

Given ED’s serious effects on patients’ physical and emotional well being, it is essential for physicians to have a better understanding of the root causes of the condition in order to help patients as soon as possible, wrote the investigators.

The studies included in the meta-analysis represented a population of 88.755 men with an average age of 56 years, with dates of the studies ranging from the inception of the databases they were taken from up until November 2016.

A majority of the studies included were conducted in Asia (61), followed by Europe (48), North America (17), Africa (15), and Oceania, South America, and multiple continents (4 in total).

South America reported the highest prevalence of ED (74.6%), while the lowest prevalence reported was among studies in North America (34.5%).

Patients who were assessed using the Sexual Health Inventory for Men (SHIM) score reported a higher ED prevalence (82.2%), as did men above the age of 60 years old (62.2%).

With ED correlated to cardiovascular health and mortality, investigators advise physicians to keep testing in mind when assessing patients’ cardiovascular risk.

This study was limited by incomplete data from studies included, which made it difficult to determine prevalence by certain categories.

Other limitations included the lack of separation between type 1 and type 2 diabetes among many of the studies analyzed, as well as a lack of information from the studies analyzed on other risk factors concerning diabetes-related erectile dysfunction.

Investigators reported no relevant financial disclosures.

On Twitter @eaztweets

Recommended Reading

Statement warns of drugs causing or exacerbating heart failure
MDedge Psychiatry
Type 2 diabetes peer-led intervention in primary care tied to improved depression symptoms
MDedge Psychiatry
VIDEO: Is your patient clinically depressed, or is there something else?
MDedge Psychiatry
Landmark psychosocial guidelines for diabetes spark debate over the ideal vs. the practical
MDedge Psychiatry
Diabetes, ischemic heart disease, pain lead health spending
MDedge Psychiatry
Toddlers’ neurodevelopmental deficits linked with maternal diabetes
MDedge Psychiatry
Mid-life cardiovascular risk factors set stage for later-life dementia
MDedge Psychiatry
In type 2 diabetes, chronotype may affect depressive symptoms
MDedge Psychiatry
Liraglutide produced cardiometabolic benefits in patients with schizophrenia
MDedge Psychiatry
Life-long risk reduction could cut late-life dementia by up to 35%
MDedge Psychiatry

Related Articles